Biome Australia is a pioneering health technology company dedicated to developing, commercializing, and marketing innovative live biotherapeutics and complementary medicines. With a strong focus on evidence-based solutions, the company aims to leverage microbiome research to prevent disease, improve health outcomes, and enhance quality of life for individuals. Their commitment to scientific rigor and clinical validation sets them apart in the healthcare and wellness industry.
The company’s flagship brand, Activated Probiotics, represents their core mission of creating precision, practitioner-only probiotic products. By partnering with leading microbiome research organizations, Biome Australia develops targeted therapeutic solutions that address specific health challenges. Their approach combines cutting-edge scientific research with practical, accessible healthcare interventions that can be tailored to individual patient needs.
As a publicly listed company on the Australian Securities Exchange (ASX:BIO), Biome Australia maintains transparency and engagement with its investors through an open Investor Hub. The company not only focuses on product development but also emphasizes clear communication with shareholders and the broader healthcare community. Their strategic vision involves continuous innovation in microbiome-based health solutions, positioning themselves at the forefront of a rapidly evolving field of medical research and personalized healthcare.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
